ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
66,784.78
-0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PROCEPT BioRobotics Corporation (PRCT) Quote

PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation (PRCT)

NASDAQ
68.10
-0.04
(-0.06%)
Closed May 19 4:00PM
Delayed by 15 minutes
67.49
-0.61
(-0.90%)
After Hours: 7:42PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
67.49
Bid
67.05
Ask
67.75
Volume
506,290
67.44 Day's Range 68.835
24.83 52 Week Range 77.00
Market Cap
3.475B
Previous Close
68.14
Open
68.05
Last Trade
199
@
67.49
(formt)
Last Trade Time
Financial Volume
$ 34,469,898
VWAP
68.0833
Average Volume (3m)
585,352
Shares Outstanding
50,964,211
Dividend Yield
-
PE Ratio
-32.82
Earnings Per Share (EPS)
-2.08
Revenue
136.19M
Net Profit
-105.9M

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surg... PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are primarily based in the United States. Its revenue is primarily generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.procept-biorobotics.com
Headquarters
Dover, Delaware, USA
Founded
1970
PROCEPT BioRobotics Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PRCT. The last closing price for PROCEPT BioRobotics was $68.14. Over the last year, PROCEPT BioRobotics shares have traded in a share price range of $ 24.83 to $ 77.00.

PROCEPT BioRobotics currently has 50,964,211 shares outstanding. The market capitalization of PROCEPT BioRobotics is $3.48 billion. PROCEPT BioRobotics has a price to earnings ratio (PE ratio) of -32.82.

PROCEPT BioRobotics (PRCT) Options Flow Summary

PRCT Options Flow

Overall Flow

Bullish

Net Premium

32k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

PRCT Latest News

More News

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative...

May 13 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

May 07 2024
Edgar (US Regulatory)

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

May 06 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

May 03 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

May 03 2024
Edgar (US Regulatory)

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

SAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

May 01 2024
GlobeNewswire Inc.

Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

SAN JOSE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

April 29 2024
GlobeNewswire Inc.

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative...

April 23 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.996.2834645669363.57761.98556075866.45420984CS
416.6732.802046438450.827748.573080359.60335497CS
1218.6338.129349160948.867745.258535253.55519341CS
2633.5798.968160377433.927731.5753098548.92921179CS
5234.24102.97744360933.257724.8349738341.33550269CS
15632.4992.8285714286357715.3839833238.41023361CS
26032.4992.8285714286357715.3839833238.41023361CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DUOFangDD Network Group Ltd
$ 1.65
(313.74%)
104.68M
FLJFLJ Group Limited
$ 1.54
(220.90%)
57.28M
JFBRJeffs Brands Ltd
$ 0.6276
(102.45%)
37.97M
IPWiPower Inc
$ 2.89
(97.95%)
11.05M
CETXCemtrex Inc
$ 0.4851
(48.58%)
21.23M
BSFCBlue Star Foods Corporation
$ 0.0757
(-45.26%)
60.09M
SINTSiNtx Technologies Inc
$ 0.084602
(-39.57%)
156.35M
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
HSCSHeart Test Laboratories Inc
$ 7.00
(-38.11%)
348.9k
AMPGAmplitech Group Inc
$ 1.46
(-32.09%)
613.31k
CRKNCrown Electrokinetics Corporation
$ 0.171
(-28.75%)
1.74B
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
GWAVGreenwave Technology Solutions Inc
$ 0.1541
(4.05%)
1.16B
AKANAkanda Corporation
$ 0.1726
(30.26%)
566.49M
PEGYPineapple Energy Inc
$ 0.1053
(-28.85%)
219.25M

Discussion

View Full Feed
th6565 th6565 4 minutes ago
Sorry you probably bought your shares less than 3 years ago.

The thrills experience of getting over $10 profits each shares sold 3 years ago could repeat again should there be some surprises from this Wednesday ASM.
ASM
garrox garrox 4 minutes ago
Instead of throwing out all those accusations, why don’t you provide evidence and proof to support your complaints. Otherwise with just two comments to your profile you sound like a newby basher.
SGTM
Monksdream Monksdream 4 minutes ago
ZCAR new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/5/19/wwfiqIMG_8214.gif
ZCAR
PickStocks PickStocks 5 minutes ago
Sure billions coming back ……soon..
COOP
Fishhard Fishhard 5 minutes ago
I'm hanging out to watch you delusional pumpers go down in a burning ring of fire.
AXXA
uber darthium uber darthium 5 minutes ago
May I remind you OZOP is nothing more than another Brian CON way scam ?

He single handedly destroyed the life’s work of Power Conversion Technologies and destroyed their reputation.

Nothing but another CON job from CONway

Your charts are useless
OZSC
PENNY PIRATE PENNY PIRATE 5 minutes ago
JonDoe1 ... Abandoned Exchange? That Remains to be Seen IMHO! The Exchange is Still in Place! KYNC PR'ed Discussions for a Partnership, AABB Investors await the AABB PR for Clarification! Note Closure Details are also a Near Term Possibility IMO, I for One think that Preferred Shares for WC/Clive co
AABB KYNC
PickStocks PickStocks 5 minutes ago
The question is do you have any fact that Libor will payout 100’s of billions to old escrows even 1 billion….
COOP
tm3141 tm3141 6 minutes ago
same here
FMCC
Minddoc7 Minddoc7 6 minutes ago
I also believe a share buyback would catapult NSAV and make a number of us extremely well off, but is it reasonable to think they can currently afford the millions to purchase even 1 billion shares? BTW, I also am holding million+ shares and would welcome such a move!
NSAV
fink fink 7 minutes ago
Baby steps predictions till we see what is comming into this shell.

I'd predict the .22 DD, but it will trigger the same bashing that we can't get above .02
So I agree with you on .02-.03 for now.

Q1 should end that discussion Monday.
And then the CEO's f
IGPK
Stockman1010101 Stockman1010101 7 minutes ago
In summary AMC Co has the worst management around but a good business fundamentally to raise solid revenue.

in summary GME Co has the best management around but a bad and dieing business fundamentally to raise solid revenue.

if you buy AMC stock you are betting the busi
AMC GME
sillyinvestor sillyinvestor 7 minutes ago
The whole bank?

“We’re gonna need more cells…”. 😁
COOP
Monksdream Monksdream 8 minutes ago
To the best of my knowledge no Israeli tickers
zab zab 9 minutes ago
https://www.msn.com/en-us/news/politics/us-senator-rubio-says-he-won-t-accept-election-results-if-unfair/ar-BB1mFnTO?ocid=msedgntp&pc=U531&cvid=e9d875f956f74810b90dd71341283f4d&ei=10

Another republican joins the chorus, if I don't win, and get my own way, I will cry.
DJT
uber darthium uber darthium 9 minutes ago
She might, may, or possibly be no good at selecting plastic surgeons either…

In my opinion

I can’t imagine anyone effing things up as badly as you have. Except Biden. What a complete, abject failure.
DBMM
skitahoe skitahoe 10 minutes ago
I'm talking about a PR for approval, not the occurrence of the CHM meeting. I've not seen any company announce that the meeting occurred.

Gary
NWBO
LOB LOB 11 minutes ago
If you think that's true, then stop hanging around here and sell your shares.
AXXA
zab zab 11 minutes ago
Good for you, and experience, and longevity, along with the decades of watching America go through different stages of growth and failure tempers your approach to understanding what is really important in life. This is America, your goal is to reveal yourself as you move between the decades.
DJT
Chartmaster Chartmaster 11 minutes ago
Selling at 30, then buying at 90??? Is that some sorta new Crypto Thirdening like the Halving where you sell at 30, then buy at 90 leaving you with 1/3 of the shares you had at a higher price? A true "Thirdening" of your portfolio of shares? Lol! Now I'm understanding Crypto better! LMAO!!!
NSAV
XMaster2023 XMaster2023 12 minutes ago
Sometimes an end run is better than running up the middle.
NWBO
Idiot Mayor Idiot Mayor 12 minutes ago
“I am not Linda Perry. I do not nor have ever had conversations with Linda Perry concerning DBMM.”

Such a simple statement to make, Poo.

Hey LP - are we still emailing the SEC attorneys to draw attention to this company? I notice that call to action just sort of died
DBMM
JRLopehandia JRLopehandia 12 minutes ago
Canadian regulators, ABX, WPM, RG, GS, JPM, all banks, to follow Credit Suisse ...

Chilean Courts have declared HUL - 100% confess, no right of appeals, no title.

The crooked local regulators, during one year did not answer the MSX legal bell, Appeals court said HE HE H
JPM

Your Recent History

NASDAQ
PRCT
PROCEPT BioRobotics
LSE
NBDD
Nb Distressed Debt Inves...
LSE
TRIN
Trinity Exploration & Pr...
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved